Ultramicronized palmitoylethanolamide reduces inflammation an a Th1-mediated model of colitis

Ultramicronized palmitoylethanolamide reduces inflammation an a Th1-mediated model of colitis

Inflammatory bowel diseases are idiopathic relapsing disorders characterized by chronic inflammation of the intestinal tract. The aim of the present study was to examine the effect of ultramicronized palmitoylethanolamide (PEAultra), underlining its correlation with PPARα and TLR4; in particular, we...

Full description

Bibliographic Details
Main Authors:	D Impellizzeri, M Campolo, R Di Paola, G Bruschetta, D de Stefano, E Esposito, S Cuzzocrea
Format:	Article
Language:	English
Published:	SAGE Publishing 2015-04-01
Series:	European Journal of Inflammation
Online Access:	https://doi.org/10.1177/1721727X15575869

Similar Items

Co-ultramicronized palmitoylethanolamide/luteolin promotes neuronal regeneration after spinal cord injury
by: Rosalia eCrupi, et al.
Published: (2016-03-01)

Oral Ultramicronized Palmitoylethanolamide: Plasma and Tissue Levels and Spinal Anti-hyperalgesic Effect
by: Stefania Petrosino, et al.
Published: (2018-03-01)

Ultramicronized Palmitoylethanolamide and Paracetamol, a New Association to Relieve Hyperalgesia and Pain in a Sciatic Nerve Injury Model in Rat
by: Alessio Filippo Peritore, et al.
Published: (2020-05-01)

Add-on administration of ultramicronized palmitoylethanolamide in the treatment of new-onset burning mouth syndrome
by: Chirchiglia D, et al.
Published: (2019-02-01)

Oral Supplementation with Ultramicronized Palmitoylethanolamide for Joint Disease and Lameness Management in Four Jumping Horses: A Case Report
by: Enrico Gugliandolo, et al.
Published: (2020-08-01)

Ultramicronized Palmitoylethanolamide (um-PEA): A New Possible Adjuvant Treatment in COVID-19 patients
by: Annalisa Noce, et al.
Published: (2021-04-01)

Combination of Rehabilitative Therapy with Ultramicronized Palmitoylethanolamide for Chronic Low Back Pain: An Observational Study
by: Dalila Scaturro, et al.
Published: (2019-12-01)

Effect of ultramicronized-palmitoylethanolamide and co-micronized palmitoylethanolamide/polydatin on chronic pelvic pain and quality of life in endometriosis patients: An open-label pilot study
by: Stochino Loi E, et al.
Published: (2019-08-01)

Looking for a Treatment for the Early Stage of Alzheimer’s Disease: Preclinical Evidence with Co-Ultramicronized Palmitoylethanolamide and Luteolin
by: Roberta Facchinetti, et al.
Published: (2020-05-01)

ALIAmides Update: Palmitoylethanolamide and Its Formulations on Management of Peripheral Neuropathic Pain
by: Ramona D’Amico, et al.
Published: (2020-07-01)

Neuroprotective activities of palmitoylethanolamide in an animal model of Parkinson's disease.
by: Emanuela Esposito, et al.
Published: (2012-01-01)

Co-Ultramicronized Palmitoylethanolamide/Luteolin-Induced Oligodendrocyte Precursor Cell Differentiation is Associated With Tyro3 Receptor Upregulation
by: Laura Facci, et al.
Published: (2021-06-01)

Metabotropic Glutamate Receptor 5 and 8 Modulate the Ameliorative Effect of Ultramicronized Palmitoylethanolamide on Cognitive Decline Associated with Neuropathic Pain
by: Serena Boccella, et al.
Published: (2019-04-01)

Molecular evidence for the involvement of PPAR-δ and PPAR-γ in anti-inflammatory and neuroprotective activities of palmitoylethanolamide after spinal cord trauma
by: Paterniti Irene, et al.
Published: (2013-02-01)

Effect of a new formulation of micronized and ultramicronized N-palmitoylethanolamine in a tibia fracture mouse model of complex regional pain syndrome.
by: Roberta Fusco, et al.
Published: (2017-01-01)

Correction: Effect of a new formulation of micronized and ultramicronized N-palmitoylethanolamine in a tibia fracture mouse model of complex regional pain syndrome.
by: Roberta Fusco, et al.
Published: (2018-01-01)

A novel composite formulation of palmitoylethanolamide and quercetin decreases inflammation and relieves pain in inflammatory and osteoarthritic pain models
by: Domenico Britti, et al.
Published: (2017-08-01)

Ultramicronized Palmitoylethanolamide Inhibits NLRP3 Inflammasome Expression and Pro-Inflammatory Response Activated by SARS-CoV-2 Spike Protein in Cultured Murine Alveolar Macrophages
by: Alessandro Del Re, et al.
Published: (2021-09-01)

A co-ultramicronized palmitoylethanolamide/luteolin composite mitigates clinical score and disease-relevant molecular markers in a mouse model of experimental autoimmune encephalomyelitis
by: Gabriella Contarini, et al.
Published: (2019-06-01)

The beneficial use of ultramicronized palmitoylethanolamide as add-on therapy to Tapentadol in the treatment of low back pain: a pilot study comparing prospective and retrospective observational arms
by: Maria Beatrice Passavanti, et al.
Published: (2017-12-01)

Management of Acute Lung Injury: Palmitoylethanolamide as a New Approach
by: Alessio Filippo Peritore, et al.
Published: (2021-05-01)

Engineered <i>Lactobacillus paracasei</i> Producing Palmitoylethanolamide (PEA) Prevents Colitis in Mice
by: Giuseppe Esposito, et al.
Published: (2021-03-01)

The actions of cannabidiol and palmitoylethanolamide on inflammation and permeability of the gut
by: Couch, Daniel
Published: (2018)

A Palmitoylethanolamide Producing Lactobacillus paracasei Improves Clostridium difficile Toxin A-Induced Colitis
by: Giuseppe Esposito, et al.
Published: (2021-04-01)

Effect of Ultra-Micronized-Palmitoylethanolamide and Acetyl-<span style="font-variant: small-caps">l</span>-Carnitine on Experimental Model of Inflammatory Pain
by: Alessio Ardizzone, et al.
Published: (2021-02-01)

The Protective Effects of Pre- and Post-Administration of Micronized Palmitoylethanolamide Formulation on Postoperative Pain in Rats
by: Rosalba Siracusa, et al.
Published: (2020-10-01)

Antagonizing Arachidonic Acid-Derived Eicosanoids Reduces Inflammatory Th17 and Th1 Cell-Mediated Inflammation and Colitis Severity
by: Jennifer M. Monk, et al.
Published: (2014-01-01)

An Update of Palmitoylethanolamide and Luteolin Effects in Preclinical and Clinical Studies of Neuroinflammatory Events
by: Marika Cordaro, et al.
Published: (2020-03-01)

N-Palmitoylethanolamine Administration Ameliorates the Clinical Manifestation and Progression of Experimental Autoimmune Encephalomyelitis in Rodents
by: D. Impellizzeri, et al.
Published: (2014-05-01)

<i>N</i>-Palmitoylethanolamide-Oxazoline Protects against Middle Cerebral Artery Occlusion Injury in Diabetic Rats by Regulating the SIRT1 Pathway
by: Roberta Fusco, et al.
Published: (2019-09-01)

Palmitoylethanolamide/Baicalein Regulates the Androgen Receptor Signaling and NF-κB/Nrf2 Pathways in Benign Prostatic Hyperplasia
by: Ramona D’Amico, et al.
Published: (2021-06-01)

Ultramicronized N-Palmitoylethanolamine Supplementation for Long-Lasting, Low-Dosed Morphine Antinociception
by: Lorenzo Di Cesare Mannelli, et al.
Published: (2018-06-01)

Delay of Morphine Tolerance by Palmitoylethanolamide
by: Lorenzo Di Cesare Mannelli, et al.
Published: (2015-01-01)

Palmitoylethanolamide and Related ALIAmides: Prohomeostatic Lipid Compounds for Animal Health and Wellbeing
by: Enrico Gugliandolo, et al.
Published: (2020-06-01)

Traumatic brain injury leads to development of Parkinson’s disease related pathology in mice
by: Daniela Impellizzeri, et al.
Published: (2016-10-01)

The Basal Pharmacology of Palmitoylethanolamide
by: Linda Rankin, et al.
Published: (2020-10-01)

The Nutraceutical N-Palmitoylethanolamide (PEA) Reveals Widespread Molecular Effects Unmasking New Therapeutic Targets in Murine Varicocele
by: Pietro Antonuccio, et al.
Published: (2021-02-01)

Palmitoylethanolamide Counteracts Enteric Inflammation and Bowel Motor Dysfunctions in a Mouse Model of Alzheimer’s Disease
by: Vanessa D’Antongiovanni, et al.
Published: (2021-09-01)

Co-micronized palmitoylethanolamide/polydatin treatment causes endometriotic lesion regression in a rodent model of surgically-induced endometriosis
by: Rosanna Di Paola, et al.
Published: (2016-10-01)

Therapeutic Efficacy of Palmitoylethanolamide and Its New Formulations in Synergy with Different Antioxidant Molecules Present in Diets
by: Alessio Filippo Peritore, et al.
Published: (2019-09-01)